A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
03/2011
03/10/2011	US20110059935 Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS
03/10/2011	US20110059932 Liver x receptor agonists
03/10/2011	US20110059924 Chemoprevention of Colorectal Cancer by Mesalamine/Sulfasalazine
03/10/2011	US20110059922 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers
03/10/2011	US20110059917 Vitamin d3 and analogs thereof for treating alopecia
03/10/2011	US20110059916 Methods and Compositions for Inducing Torpor in a Subject
03/10/2011	US20110059911 Antiinfective and Antitumoral Compounds Isolated From Tropical Lianas
03/10/2011	US20110059901 Compositions and Methods for Treatment of Neoplastic Disease
03/10/2011	US20110059900 Diagnosing and treating hormone resistant cancers
03/10/2011	US20110059899 Kruppel-like factor 6 (KLF6), a tumor suppressor protein, and diagnostics, therapeutics, and screening based on this protein
03/10/2011	US20110059898 Pro-oxidant anti-cancer compounds
03/10/2011	US20110059893 Compounds for the treatment of proliferative disorders
03/10/2011	US20110059890 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas
03/10/2011	US20110059889 PEPTIDES THAT BLOCK THE BINDING OF IgG TO FcRn
03/10/2011	US20110059888 Metastin derivatives and use thereof
03/10/2011	US20110059885 Treatment of diseases and conditions mediated by eicosanoids
03/10/2011	US20110059524 Human cdr-grafted antibody and antibody fragment thereof
03/10/2011	US20110059189 Method and composition for treating cancer, effecting apoptosis and treating retroviral infections
03/10/2011	US20110059187 Peptide dicer substrate agents and methods for their specific inhibition of gene expression
03/10/2011	US20110059186 Cancer stem cell-targeted and drug resistant cancer therapy
03/10/2011	US20110059183 Water-insoluble medicine
03/10/2011	US20110059181 Methods for drug delivery comprising unfolding and folding proteins and peptide nanoparticles
03/10/2011	US20110059180 Method for Preparing Nanoparticles Based on Functional Amphiphilic Molecules or Macromolecules, and the Use Thereof
03/10/2011	US20110059167 Encapsulation of biologically active agents
03/10/2011	US20110059161 Targeted delivery using tissue-specific peptidomimetic ligands
03/10/2011	US20110059159 Nanoscale bound bilayers, methods of use and production
03/10/2011	US20110059137 Chemokine gene-modified cells for cancer immunotherapy
03/10/2011	US20110059135 Capsid-Incorporated Antigen for Novel Adenovirus Vaccine
03/10/2011	US20110059124 The quality control method and application of a kind of ganoderma lucidum spore oil fat emulsion
03/10/2011	US20110059123 Inhibition of the Survival of Colorectal Cancer by Cyclohexenone Compounds from Antrodia Camphorata
03/10/2011	US20110059122 Inhibition of the Survival of Oral Cavity Cancer by Cyclohexenone Compounds from Antrodia Camphorata
03/10/2011	US20110059118 Inhibitors of jak
03/10/2011	US20110059114 Compositions and Methods for the Treatment of Radioresistant Glioma Stem Cells
03/10/2011	US20110059113 Gab2 amplification in melanoma
03/10/2011	US20110059112 Anti-robo4 antibodies and uses therefor
03/10/2011	US20110059109 Methods for inducing or enhancing an immune response by administering GITR-binding antibodies
03/10/2011	US20110059108 Methods of modulating apoptosis by administration of relaxin agonists or antagonists
03/10/2011	US20110059106 Methods for modulating a population of myeloid-derived suppressor cells and uses thereof
03/10/2011	US20110059105 Tie complex binding proteins
03/10/2011	US20110059104 Apo-2L receptor agonist and CPT-11 synergism
03/10/2011	US20110059101 Amino Acid Sequences Directed Against Il-6 And Polypetides Comprising The Same For The Treatment Of Diseases And Disorders Associated With Il-6 Mediated Signalling
03/10/2011	US20110059097 MFAP4 as a Marker For Regulatory Cells and Anti-Cancer Cells
03/10/2011	US20110059096 Targeting of Notch3 Receptor Function for Cancer Therapy
03/10/2011	US20110059095 High affinity human antibodies to human protease-activated receptor-2
03/10/2011	US20110059094 Antitumor effects of insulin-responsive dna binding protein-1 (irdbp-1)
03/10/2011	US20110059091 Inhibitors of oncogenic isoforms and uses thereof
03/10/2011	US20110059090 Amino acid sequences directed against her2 and polypeptides comprising the same for the treatment of cancers and/or tumors
03/10/2011	US20110059088 Protein involved in ovarian cancer
03/10/2011	US20110059081 Methods and compositions for the treatment of receptor tyrosine kinase mediated diseases or disorders
03/10/2011	US20110059080 Use of an anti-il6 antibody to decrease hepcidin in cancer patients
03/10/2011	US20110059076 Human serum albumin linkers and conjugates thereof
03/10/2011	US20110059074 Knowledge-Based Proliferation Signatures and Methods of Use
03/10/2011	US20110059073 Method for treating infectious disease using monoclonal antibodies
03/10/2011	US20110059072 Method for treating cancer using monoclonal antibodies
03/10/2011	US20110059070 Combination therapy for tumoral desease treatment
03/10/2011	US20110059069 Gapr-1 Methods
03/10/2011	US20110059068 Polypeptides involved in immune response
03/10/2011	US20110059067 Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides
03/10/2011	US20110059066 PAKs as Modifiers of the CHK Pathway and Methods of Use
03/10/2011	US20110059065 Function and regulation of adamts-1
03/10/2011	US20110059054 Enhanced dendritic cells for cancer immunotherapy
03/10/2011	US20110059050 Methods and compositions relating to stem cell transplantation
03/10/2011	US20110059049 Poxviral oncolytic vectors
03/10/2011	US20110059046 Derivatives of gefitinib
03/10/2011	US20110059045 Pharmaceutical composition for cancer treatment
03/10/2011	US20110059042 Substituted il-15
03/10/2011	US20110059024 Liposome composition, and diagnostic contrast agent, therapeutic enhancer, and pharmaceutical composition using the same
03/10/2011	US20110059023 Narrowband imaging using near-infrared absorbing nanoparticles
03/10/2011	US20110059016 Optical assay system with a multi-probe imaging array
03/10/2011	US20110059012 Identification of cd8+ t cells that are cd161hi and/or il18r (alpha) hi and have rapid drug efflux capacity
03/10/2011	US20110059011 Diagnosis and treatment of diseased and damaged tissue
03/10/2011	US20110059010 Dual phase drug release system
03/10/2011	CA2810119A1 Clec14a inhibitors
03/10/2011	CA2780713A1 Monoclonal antibodies against gonadotropin-releasing hormone receptor
03/10/2011	CA2773146A1 P2x7: inhibition of epithelial cancers and papillomas
03/10/2011	CA2773083A1 Immunity-inducing agent
03/10/2011	CA2772871A1 Pharmaceutical formulations for indibulin
03/10/2011	CA2772718A1 Compounds as tyrosine kinase modulators
03/10/2011	CA2772714A1 Heterocyclic compounds for the inhibition of pask
03/10/2011	CA2772625A1 Compounds as tyrosine kinase modulators
03/10/2011	CA2772616A1 Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer
03/10/2011	CA2772614A1 Compounds and compositions for treating cancer
03/10/2011	CA2772265A1 Pyrazinylpyridines useful for the treatment of proliferative diseases
03/10/2011	CA2772212A1 Desferrithiocin polyether analogues and uses thereof
03/10/2011	CA2772194A1 Benzimidazole derivatives
03/10/2011	CA2772057A1 Targeted delivery using tissue-specific peptidomimetic ligands
03/10/2011	CA2771900A1 Tumoricidal, bactericidal, or viricidal macrophage activation
03/10/2011	CA2771822A1 Bruton's tyrosine kinase inhibitors
03/10/2011	CA2771563A1 Bipyridines useful for the treatment of proliferative diseases
03/10/2011	CA2771016A1 Kinase inhibitors, prodrug forms thereof and their use in therapy
03/10/2011	CA2694467A1 New method treatment the diseases, which use vitamin e oil in big doses so that of incurable (cancer, arthritis), chronic (diabetes, hypertension), infection (inflammation, virus,bacterium, fungus), regeneration damages (skin, tissue, conjunctive tissue), and in the look the applique, and covering by film
03/09/2011	EP2292771A2 Sense mRNA therapy
03/09/2011	EP2292734A1 Hematopoietic cells from human embryonic stem cells
03/09/2011	EP2292666A2 Neoplasm specific antibodies and uses thereof
03/09/2011	EP2292660A2 Human antibody molecules for IL-13
03/09/2011	EP2292655A1 Peptides and related molecules that bind to tall-1
03/09/2011	EP2292652A2 Interferons uses and compositions related thereto
03/09/2011	EP2292639A1 Tubulisine derivatives as anticancer drugs
03/09/2011	EP2292634A2 Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
03/09/2011	EP2292632A2 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes

1 ... 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 ... 2211